News

C5a receptor is a component of the body’s complement system and a potent driver of the inflammatory response associated with autoimmune diseases, such as systemic lupus erythematosus, certain

The approval is based on the positive results from the international ToGA trial, which showed that treatment with Herceptin prolongs the lives of patients with this aggressive cancer.

The company said that the Nasal spray ZT-034 is being developed as an alternative to Eli Lilly’s Forteo (teriparatide [rDNA origin]), for the treatment of osteoporosis, and is

Stirling’s botanical extract, ImmunoXel has already been shown to decrease the duration of the flu in clinical trial participants by 2 – 3 days. The company claims that

In the Notice Letter, Teva alleges that three patents associated with Tenofovir Disoproxil – US Patent numbers 5922695, 5977089 and 6043230, and one patent associated with Tenofovir Disoproxil

The study results demonstrated that Rotarix prevented the disease in 61.2% of these infants. It also showed that Rotarix provided broad protection against diverse circulating rotavirus strains and

Research and development across Atlantic Canada is benefiting from an important federal investment of $62.4m, under Round VII of the Atlantic Innovation Fund (AIF). Reportedly, in the island,

Reportedly, Novella will assume the use of some of OSI’s facilities in Boulder and employ members of OSI’s Boulder staff. OSI had previously announced plans to consolidate its

The company reported that the patient was given a single dose of 1 X 109 viral particles of Ad-VEGF-D and has been moved from post operative critical care